US Bancorp DE boosted its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 29.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,549 shares of the company's stock after purchasing an additional 6,975 shares during the quarter. US Bancorp DE's holdings in Nutrien were worth $1,367,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in NTR. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Nutrien during the third quarter valued at approximately $150,181,000. ARGA Investment Management LP increased its holdings in shares of Nutrien by 25.7% in the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock valued at $270,396,000 after purchasing an additional 1,236,671 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock valued at $121,271,000 after purchasing an additional 1,100,000 shares during the last quarter. Silchester International Investors LLP increased its holdings in shares of Nutrien by 9.5% in the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock valued at $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. Finally, Toronto Dominion Bank increased its holdings in shares of Nutrien by 11.9% in the third quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company's stock valued at $202,830,000 after purchasing an additional 447,413 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Price Performance
Shares of Nutrien stock traded down $0.12 during trading on Friday, hitting $51.03. 2,899,943 shares of the company were exchanged, compared to its average volume of 1,985,228. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a fifty-two week low of $43.70 and a fifty-two week high of $60.87. The stock has a market capitalization of $24.96 billion, a price-to-earnings ratio of 37.24, a P/E/G ratio of 1.19 and a beta of 0.81. The firm has a 50 day moving average price of $50.71 and a 200 day moving average price of $48.58.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. On average, equities analysts expect that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.
Nutrien Cuts Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be given a dividend of $0.545 per share. The ex-dividend date is Monday, March 31st. This represents a $2.18 annualized dividend and a dividend yield of 4.27%. Nutrien's dividend payout ratio is currently 159.12%.
Analyst Ratings Changes
NTR has been the subject of several recent research reports. Scotiabank increased their price target on Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a report on Monday, February 24th. CIBC increased their price objective on Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a research report on Tuesday, February 25th. Wells Fargo & Company increased their price objective on Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Oppenheimer initiated coverage on Nutrien in a research report on Thursday, December 12th. They issued an "outperform" rating and a $60.00 price objective for the company. Finally, Raymond James upgraded Nutrien from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $60.13.
Get Our Latest Stock Report on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
